AZURRX SAS has a total of 11 patent applications. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), Australia and Brazil. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are QUINTESSENCE BIOSCIENCES INC, TALECRIS BIOTHERAPEUTICS INC and PORTAGE PHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | France | 1 | |
#7 | Mexico | 1 | |
#8 | Singapore | 1 | |
#9 | United States | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Jais Philippe | 9 |
#2 | Dupret Daniel | 9 |
#3 | Schue Mathieu | 9 |
#4 | Mathieu Schue | 2 |
#5 | Philippe Jais | 2 |
#6 | Daniel Dupret | 2 |
Publication | Filing date | Title |
---|---|---|
FR3027307A1 | Hybrid protein molecule capable of inhibiting at least one antibiotic and pharmaceutical composition comprising the same |